Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
暂无分享，去创建一个
S. Linn | J. Wesseling | E. van Werkhoven | L. Tick | G. Sonke | M. V. Vrancken Peeters | L. V. van Warmerdam | V. Dezentjé | I. Mandjes | M. V. Vrancken Peeters | C. Mandigers | I. Oving | A. J. van de Wouw | A. Honkoop | A. van der Voort | M. V. van Ramshorst | I. Kemper | Inge Kemper | V. Dezentjé